IP Verse

Alexion Pharmaceuticals patent opposition analysis

Get complete Patent Opposition Report for Alexion Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Alexion Pharmaceuticals

Explore patent oppositions filed by Alexion Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2708559Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 31, 2018
EP2708558Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 21, 2018
EP2552955Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 2, 2018

Latest patents of Alexion Pharmaceuticals opposed by its competitors

Explore Alexion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3167888May 1, 2024Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement2
EP2894165Jan 4, 2023Methods And Compositions For Treating Complement-Associated Disorders2
EP2978451Nov 27, 2019Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C52
EP3207132Jul 31, 2019Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof1

Top competitors of Alexion Pharmaceuticals